- Zacks
Down -8.97% in 4 Weeks, Here's Why You Should You Buy the Dip in LifeStance Health (LFST)
The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- Insider Monkey
LifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2024 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2024 Earnings Call Transcript May 11, 2024 LifeStance Health Group, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Alex, and I will be your conference […]
- Zacks
LifeStance Health Group (LFST) Reports Q1 Loss, Tops Revenue Estimates
LifeStance Health (LFST) delivered earnings and revenue surprises of 33.33% and 0.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
